Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 23253663)

1.

Yale Center for Clinical Investigation: leveraging industry partnerships and research cores.

Sherwin R, Slayman C, Rockwell S, Herold K, Williams K, Carson R, Mane S, Seow H, Max J, Johnson T.

Clin Transl Sci. 2012 Dec;5(6):435-6. doi: 10.1111/cts.12016. No abstract available.

PMID:
23253663
2.

Public-private relationships in biobanking: a still underestimated key component of open innovation.

Hofman P, Bréchot C, Zatloukal K, Dagher G, Clément B.

Virchows Arch. 2014 Jan;464(1):3-9. doi: 10.1007/s00428-013-1524-z. Epub 2013 Dec 14. Review.

PMID:
24337181
3.

Public-private partnerships in translational medicine: concepts and practical examples.

Luijten PR, van Dongen GA, Moonen CT, Storm G, Crommelin DJ.

J Control Release. 2012 Jul 20;161(2):416-21. doi: 10.1016/j.jconrel.2012.03.012. Epub 2012 Mar 20. Review.

PMID:
22465390
4.

The Innovative Medicines Initiative moves translational immunology forward.

Goldman M, Wittelsberger A, De Magistris MT.

Eur J Immunol. 2013 Feb;43(2):298-302. Review.

PMID:
23534061
5.

Principles for building public-private partnerships to benefit food safety, nutrition, and health research.

Rowe S, Alexander N, Kretser A, Steele R, Kretsch M, Applebaum R, Clydesdale F, Cummins D, Hentges E, Navia J, Jarvis A, Falci K.

Nutr Rev. 2013 Oct;71(10):682-91. doi: 10.1111/nure.12072. Review.

6.
7.

Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.

Wellenreuther R, Keppler D, Mumberg D, Ziegelbauer K, Lessl M.

Drug Discov Today. 2012 Nov;17(21-22):1242-8. doi: 10.1016/j.drudis.2012.04.004. Epub 2012 Apr 12. Review.

PMID:
22521665
8.

CTSA-IP: a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.

Hazard M, Steele S, Wang D, Pearson T, Scheideler M, Dewhurst S.

Clin Transl Sci. 2011 Oct;4(5):328-31. doi: 10.1111/j.1752-8062.2011.00308.x. Review. Erratum in: Clin Transl Sci. 2012 Feb;5(1):112.

9.

New opportunities and novel paradigms to support neuromuscular research.

Lieber R, Ward S, Frank L, Schenk S.

Phys Med Rehabil Clin N Am. 2012 Feb;23(1):95-105, xi. doi: 10.1016/j.pmr.2011.11.015. Review.

PMID:
22239877
10.

Challenges for pharmaceutical industry: new partnerships for sustainable human health.

Hunter J.

Philos Trans A Math Phys Eng Sci. 2011 May 13;369(1942):1817-25. doi: 10.1098/rsta.2010.0377. Review.

PMID:
21464073
11.

Public-private collaborations and partnerships in stratified medicine: making sense of new interactions.

Chataway J, Fry C, Marjanovic S, Yaqub O.

N Biotechnol. 2012 Sep 15;29(6):732-40. doi: 10.1016/j.nbt.2012.03.006. Epub 2012 Mar 17. Review.

PMID:
22446473
12.

[Expectation for the drug development activity in academia].

Inagaki O.

Yakugaku Zasshi. 2013;133(2):213-9. Review. Japanese.

13.

Academia-industry collaboration: an integral element for building "omic" resources.

Hill DE, Brasch MA, del Campo AA, Doucette-Stamm L, Garrels JI, Glaven J, Hartley JL, Hudson JR Jr, Moore T, Vidal M.

Genome Res. 2004 Oct;14(10B):2010-4. Review. No abstract available.

14.

Medical education and research environment in Qatar: a new epoch for translational research in the Middle East.

Chouchane L, Mamtani R, Al-Thani MH, Al-Thani AA, Ameduri M, Sheikh JI.

J Transl Med. 2011 Jan 27;9:16. doi: 10.1186/1479-5876-9-16. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk